Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
TEL AVIV STOCK EXCHANGE
17:27:07 07/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 10,910.00 ILa | -0.46% |
|
-1.09% | +8.13% |
| 09-04 | S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-' | MT |
| 09-04 | Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data | MT |
| Market Cap | 42.37B 0 36.44B 34.27B 31.28B 58.51B 4,007B 58.7B 406B 157B 2,052B 159B 156B 6,536B | P/E 2026 * |
48.8x | P/E 2027 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 54.27B 0 46.67B 43.9B 40.07B 74.95B 5,133B 75.19B 521B 201B 2,629B 204B 199B 8,373B | EV / Sales 2026 * |
3.27x | EV / Sales 2027 * | 2.95x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| TEVA | Delayed | |
OTC Markets
| TEVJF | Delayed |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | -0.46% | ||
| 1 week | +1.87% | ||
| Current month | +1.87% | ||
| 1 month | +3.90% | ||
| 3 months | +7.07% | ||
| 6 months | +15.76% | ||
| Current year | +8.13% |
| 1 week | 10,780 |  | 11,530 |
| 1 month | 10,450 | | 11,530 |
| Current year | 8,860 | | 11,530 |
| 1 year | 6,082 | | 11,530 |
| 3 years | 3,250 | | 11,530 |
| 5 years | 2,383 | | 11,530 |
| 10 years | 2,175 | | 19,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | +1.87% | - | - | 42.37B | |
| -0.88% | -2.15% | +58.05% | +105.26% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +74.19% | 663B | |
| -1.44% | +0.38% | +20.65% | +76.13% | 453B | |
| -0.95% | +0.23% | +30.91% | +37.78% | 352B | |
| -3.18% | +1.78% | +22.62% | +41.55% | 304B | |
| +0.30% | +0.67% | +0.60% | +11.25% | 252B | |
| -1.55% | +1.11% | +54.15% | +75.59% | 236B | |
| +0.02% | +2.24% | -13.83% | -55.80% | 206B | |
| -0.15% | +3.65% | +31.24% | +103.39% | 187B | |
| Average | -0.93% | +1.26% | +28.74% | +52.15% | 408.71B | |
| Weighted average by Cap. | -1.04% | +0.62% | +37.66% | +66.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.59B 0 14.27B 13.42B 12.25B 22.91B 1,569B 22.98B 159B 61.5B 804B 62.31B 60.94B 2,559B | 17.3B 0 14.88B 14B 12.78B 23.9B 1,637B 23.97B 166B 64.15B 838B 64.99B 63.57B 2,670B |
| Net income | 1.44B 0 1.24B 1.17B 1.06B 1.99B 136B 2B 13.82B 5.34B 69.79B 5.41B 5.29B 222B | 2.69B 0 2.31B 2.17B 1.99B 3.71B 254B 3.72B 25.78B 9.97B 130B 10.1B 9.88B 415B |
| Net Debt | 11.9B 0 10.24B 9.63B 8.79B 16.44B 1,126B 16.49B 114B 44.12B 576B 44.7B 43.72B 1,836B | 8.65B 0 7.44B 7B 6.39B 11.95B 818B 11.99B 82.98B 32.07B 419B 32.49B 31.78B 1,335B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/09/26 | ILA 10,910.00 | -0.46% | 499,288 |
| 04/09/26 | ILA 10,960.00 | -0.36% | 473,654 |
| 03/09/26 | ILA 11,000.00 | -0.09% | 983,311 |
| 02/09/26 | ILA 11,010.00 | -0.09% | 1,791,302 |
| 01/09/26 | ILA 11,020.00 | +2.89% | 1,141,409 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
